cyproheptadine has been researched along with ADDH in 5 studies
Cyproheptadine: A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc.
cyproheptadine : The product resulting from the formal oxidative coupling of position 5 of 5H-dibenzo[a,d]cycloheptene with position 4 of 1-methylpiperidine resulting in the formation of a double bond between the two fragments. It is a sedating antihistamine with antimuscarinic and calcium-channel blocking actions. It is used (particularly as the hydrochloride sesquihydrate) for the relief of allergic conditions including rhinitis, conjunctivitis due to inhalant allergens and foods, urticaria and angioedema, and in pruritic skin disorders. Unlike other antihistamines, it is also a seratonin receptor antagonist, making it useful in conditions such as vascular headache and anorexia.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This research evaluates the preventive effects of cyproheptadine on sleeping and appetite disorders induced by methylphenidate in ADHD children." | 9.30 | Preventive effect of cyproheptadine on sleep and appetite disorders induced by methylphenidate: an exploratory randomised, double-blinded, placebo-controlled clinical trial. ( Elyasi, S; Kadkhoda Mezerji, F; Mohammadpour, AH; Moharreri, F, 2019) |
| "Cyproheptadine has been shown in medical samples to stimulate weight gain." | 5.32 | A chart review of cyproheptadine for stimulant-induced weight loss. ( Daviss, WB; Scott, J, 2004) |
| " This research evaluates the preventive effects of cyproheptadine on sleeping and appetite disorders induced by methylphenidate in ADHD children." | 5.30 | Preventive effect of cyproheptadine on sleep and appetite disorders induced by methylphenidate: an exploratory randomised, double-blinded, placebo-controlled clinical trial. ( Elyasi, S; Kadkhoda Mezerji, F; Mohammadpour, AH; Moharreri, F, 2019) |
| "Cyproheptadine has been shown in medical samples to stimulate weight gain." | 1.32 | A chart review of cyproheptadine for stimulant-induced weight loss. ( Daviss, WB; Scott, J, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kadkhoda Mezerji, F | 1 |
| Moharreri, F | 1 |
| Mohammadpour, AH | 1 |
| Elyasi, S | 1 |
| Daviss, WB | 1 |
| Scott, J | 1 |
| Kratochvil, CJ | 1 |
| Lake, M | 1 |
| Pliszka, SR | 1 |
| Walkup, JT | 1 |
| Cortese, S | 1 |
| Lecendreux, M | 1 |
| Mouren, MC | 1 |
| Konofal, E | 1 |
| Calmels, JP | 1 |
| Sorbette, F | 1 |
| Montastruc, JL | 1 |
| Albarede, JL | 1 |
1 review available for cyproheptadine and ADDH
| Article | Year |
|---|---|
Pharmacological management of treatment-induced insomnia in ADHD.
Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimula | 2005 |
1 trial available for cyproheptadine and ADDH
| Article | Year |
|---|---|
Preventive effect of cyproheptadine on sleep and appetite disorders induced by methylphenidate: an exploratory randomised, double-blinded, placebo-controlled clinical trial.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Pres | 2019 |
3 other studies available for cyproheptadine and ADDH
| Article | Year |
|---|---|
A chart review of cyproheptadine for stimulant-induced weight loss.
Topics: Adolescent; Anti-Obesity Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous Syst | 2004 |
ADHD and insomnia.
Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimula | 2006 |
[Iatrogenic hyperkinetic syndrome caused by an antihistaminic].
Topics: Aged; Attention Deficit Disorder with Hyperactivity; Cyproheptadine; Humans; Male | 1982 |